Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila

Human Molecular Genetics

Volumn 20, Issue 19, 2011, Pages 3738-3745

  Talmat Amar, Yasmina ^a,b   Arribat, Yoan ^a,b   Redt Clouet, Christelle ^a,b   Feuillette, Sébastien ^c   Bougé, Anne Laure ^a,b   Lecourtois, Magalie ^c   Parmentier, Marie Laure ^a,b  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b UNIV MONTPELLIER   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROHORMONE; TAU PROTEIN;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXICITY; DROSOPHILA; HORMONE RELEASE; IN VIVO STUDY; MALE; MICROTUBULE; NERVE CELL; NERVE FIBER TRANSPORT; NEURONAL TOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; AXONAL TRANSPORT; DISEASE MODELS, ANIMAL; DROSOPHILA; FEMALE; HUMANS; MALE; MICROTUBULES; NEURONS; PHOSPHORYLATION; PROTEIN ISOFORMS; TAU PROTEINS; TAUOPATHIES;

EID: 80052696800     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr290     Document Type: Article

References (37)

1. Sergeant, N., Bretteville, A., Hamdane, M., Caillet-Boudin, M.L., Grognet, P., Bombois, S., Blum, D., Delacourte, A., Pasquier, F., Vanmechelen, E. et al. (2008) Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev. Proteomics, 5, 207-224.
2. Mandelkow, E.M., Biernat, J., Drewes, G., Gustke, N., Trinczek, B. and Mandelkow, E. (1995) Tau domains, phosphorylation, and interactions with microtubules. Neurobiol. Aging, 16, 355-362; discussion 362-3.
3. Spires-Jones, T.L., Stoothoff, W.H., de Calignon, A., Jones, P.B. and Hyman, B.T. (2009) Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci., 32, 150-159.
4. Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B. and Mandelkow, E. (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell Biol., 143, 777-794.
5. Stamer, K., Vogel, R., Thies, E., Mandelkow, E. and Mandelkow, E.M. (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol., 156, 1051-1063.
6. Trinczek, B., Ebneth, A., Mandelkow, E.M. and Mandelkow, E. (1999) Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J. Cell Sci., 112, 2355-2367.
7. Dixit, R., Ross, J.L., Goldman, Y.E. and Holzbaur, E.L. (2008) Differential regulation of dynein and kinesin motor proteins by tau. Science, 319, 1086-1089.
8. Seitz, A., Kojima, H., Oiwa, K., Mandelkow, E.M., Song, Y.H. and Mandelkow, E. (2002) Single-molecule investigation of the interference between kinesin, tau and MAP2c. EMBO J., 21, 4896-4905.
9. Vershinin, M., Carter, B.C., Razafsky, D.S., King, S.J. and Gross, S.P. (2007) Multiple-motor based transport and its regulation by Tau. Proc. Natl Acad. Sci. USA, 104, 87-92.
10. Ishihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M.K., Trojanowski, J.Q. and Lee, V.M. (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron, 24, 751-762.
11. Probst, A., Gotz, J., Wiederhold, K.H., Tolnay, M., Mistl, C., Jaton, A.L., Hong, M., Ishihara, T., Lee, V.M., Trojanowski, J.Q. et al. (2000) Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol., 99, 469-481.
12. Spittaels, K., Van den Haute, C., Van Dorpe, J., Bruynseels, K., Vandezande, K., Laenen, I., Geerts, H., Mercken, M., Sciot, R., Van Lommel, A. et al. (1999) Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol., 155, 2153-2165.
13. Spittaels, K., Van den Haute, C., Van Dorpe, J., Geerts, H., Mercken, M., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T. et al. (2000) Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J. Biol. Chem., 275, 41340-41349.
14. Yuan, A., Kumar, A., Peterhoff, C., Duff, K. and Nixon, R.A. (2008) Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice. J. Neurosci., 28, 1682-1687.
15. Mudher, A., Shepherd, D., Newman, T.A., Mildren, P., Jukes, J.P., Squire, A., Mears, A., Drummond, J.A., Berg, S., MacKay, D. et al. (2004) GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol. Psychiatry, 9, 522-530.
16. Khurana, V., Lu, Y., Steinhilb, M.L., Oldham, S., Shulman, J.M. and Feany, M.B. (2006) TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr. Biol., 16, 230-241.
17. Fulga, T.A., Elson-Schwab, I., Khurana, V., Steinhilb, M.L., Spires, T.L., Hyman, B.T. and Feany, M.B. (2007) Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat. Cell Biol., 9, 139-148.
18. Anthis, N.J., Haling, J.R., Oxley, C.L., Memo, M., Wegener, K.L., Lim, C.J., Ginsberg, M.H. and Campbell, I.D. (2009) Beta integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation. J. Biol. Chem., 284, 36700-36710.
19. Gindhart, J.G. Jr, Desai, C.J., Beushausen, S., Zinn, K. and Goldstein, L.S. (1998) Kinesin light chains are essential for axonal transport in Drosophila. J. Cell Biol., 141, 443-454.
20. Hurd, D.D. and Saxton, W.M. (1996) Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila. Genetics, 144, 1075-1085.
21. Luan, H., Lemon, W.C., Peabody, N.C., Pohl, J.B., Zelensky, P.K., Wang, D., Nitabach, M.N., Holmes, T.C. and White, B.H. (2006) Functional dissection of a neuronal network required for cuticle tanning and wing expansion in Drosophila. J. Neurosci., 26, 573-584.
22. Loveall, B.J. and Deitcher, D.L. (2010) The essential role of bursicon during Drosophila development. BMC Dev. Biol., 10, 92.
23. Peabody, N.C., Diao, F., Luan, H., Wang, H., Dewey, E.M., Honegger, H.W. and White, B.H. (2008) Bursicon functions within the Drosophila CNS to modulate wing expansion behavior, hormone secretion, and cell death. J. Neurosci., 28, 14379-14391.
24. Morfini, G., Pigino, G., Mizuno, N., Kikkawa, M. and Brady, S.T. (2007) Tau binding to microtubules does not directly affect microtubule-based vesicle motility. J. Neurosci. Res., 85, 2620-2630.
25. Bunker, J.M., Wilson, L., Jordan, M.A. and Feinstein, S.C. (2004) Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration. Mol. Biol. Cell, 15, 2720-2728.
26. Rosenberg, K.J., Ross, J.L., Feinstein, H.E., Feinstein, S.C. and Israelachvili, J. (2008) Complementary dimerization of microtubule-associated tau protein: implications for microtubule bundling and tau-mediated pathogenesis. Proc. Natl Acad. Sci. USA, 105, 7445-7450.
27. Liu, F., Li, B., Tung, E.J., Grundke-Iqbal, I., Iqbal, K. and Gong, C.X. (2007) Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation. Eur. J. Neurosci., 26, 3429-3436.
28. Wang, J.Z., Grundke-Iqbal, I. and Iqbal, K. (2007) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur. J. Neurosci., 25, 59-68.
29. Feuillette, S., Miguel, L., Frebourg, T., Campion, D. and Lecourtois, M. (2010) Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein. J. Neurochem., 113, 895-903.
30. Grammenoudi, S., Anezaki, M., Kosmidis, S. and Skoulakis, E.M. (2008) Modelling cell and isoform type specificity of tauopathies in Drosophila. SEB Exp. Biol. Ser., 60, 39-56.
31. Steinhilb, M.L., Dias-Santagata, D., Fulga, T.A., Felch, D.L. and Feany, M.B. (2007) Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Mol. Biol. Cell, 18, 5060-5068.
32. Yeh, P.A., Chien, J.Y., Chou, C.C., Huang, Y.F., Tang, C.Y., Wang, H.Y. and Su, M.T. (2010) Drosophila notal bristle as a novel assessment tool for pathogenic study of Tau toxicity and screening of therapeutic compounds. Biochem. Biophys. Res. Commun., 391, 510-516.
33. Jackson, G.R., Wiedau-Pazos, M., Sang, T.K., Wagle, N., Brown, C.A., Massachi, S. and Geschwind, D.H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron, 34, 509-519.
34. Nishimura, I., Yang, Y. and Lu, B. (2004) PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell, 116, 671-682.
35. Steinhilb, M.L., Dias-Santagata, D., Mulkearns, E.E., Shulman, J.M., Biernat, J., Mandelkow, E.M. and Feany, M.B. (2007) S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. J. Neurosci. Res., 85, 1271-1278.
36. Chatterjee, S., Sang, T.K., Lawless, G.M. and Jackson, G.R. (2009) Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Hum. Mol. Genet., 18, 164-177.
37. Franco, B., Bogdanik, L., Bobinnec, Y., Debec, A., Bockaert, J., Parmentier, M.L. and Grau, Y. (2004) Shaggy, the homolog of glycogen synthase kinase 3, controls neuromuscular junction growth in Drosophila. J. Neurosci., 24, 6573-6577.